选择性向基化酶,以开发强效的抗寄生虫药物
Shahbaz M Khan1, Md Mukthar Mia2, William H Witola2
1W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Trends in parasitology
|November 16, 2024
概括
研究人员验证了Cryptosporidium PDE1作为药物标,识别了有效抑制这种酶和对抗密度化症的pyrazolopyrimidines.
科学领域:
- 生物化学 生化学
- 寄生虫学的寄生虫学
- 药物发现 药物发现 药物发现
背景情况:
- 细胞内循环核酸水平由固酶 (PDEs) 调节,以维持细胞平衡.
- 循环核酸的失调会导致各种生理不平衡.
- 固酶是治疗干预的关键目标类.
研究的目的:
- 验证Cryptosporidium PDE1 (CpPDE1) 作为一种潜在的药物标,用于治疗密码化症.
- 识别和优化具有针对CPPDE1.1的选择性抑制活性的新型化合物.
- 为了评估已识别的化合物的抗密体效果.
主要方法:
- 进行了酶抑制试验,以评估化合物对CpPDE1.1的活性.
- 对人类PDE异型进行了选择性分析,以确保目标特异性.
- 试验室试验被用来确定优化化合物的抗密体有效性.
主要成果:
- 加密 PDE1 (CpPDE1) 已被验证为一个有前途的药物标.
- 经过优化后的pyrazolopyrimidine化合物显示出强大而有选择性的抑制CPPDE1.1.
- 这些化合物表现出显著的抗密体活性,优于现有的治疗方法.
结论:
- CpPDE1 是一种可行的治疗点,用于密码化症.
- 优化的pyrazolopyrimidines为治疗密码化症提供了一个有前途的新类药物.
- 已识别的化合物显示出进一步发展成为有效的抗密体治疗疗法的潜力.
更多相关视频
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
11.8K
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.1K
相关概念视频
02:54Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
01:26Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K